Saturday, August 21, 2021 11:17:43 AM
Oy. Kite was an established NASDAQ traded company with an active pipeline with drugs in clinical trials with real world clinical trial data. Regen is a bankrupt pinky stinky with nothing but IP that isn't proven at all. This comparison is one made on a false premise. No major pharma is going to buy RGBP for its IP.
RGBP is trading on hype and hyperbole. The con is on.
RGBP is trading on hype and hyperbole. The con is on.
FACTS are stubborn things
Recent RGBP News
- Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 • GlobeNewswire Inc. • 09/23/2025 12:00:00 PM
- Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate • GlobeNewswire Inc. • 09/16/2025 12:00:00 PM
